Abstract
The discovery of drugs bringing about blockade of sympathetic ganglia has been an important step in the development of modern antihypertensive therapy. Partially successful clinical use of tetraethylammonium had initiated the synthesis and pharmacological studies on more than one thousand new substances with one or two quaternary nitrogen atoms in the molecule. It has been intended to find a drug with higher ganglion-blocking activity and long lasting hypotensive effect with less side-effects. These studies have led to the development of several drugs which were used for some years in therapeutic practice. Tetraethylammonium (1), hexa-methonium (2), pentolinium (3), chlorisondamin (4), azamethonium (5), trimethydinium (6) and pentacynium (7) were the most important of them (see Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D’Arcy, P.F., Taylor, E.P.: Quaternary ammonium compounds in medicinal chemistry. I. J. Pharm. Pharmacol. 14, 129–146 (1962)
Barlow, R.B., Ing, H.R.: Curare-like action of polymethylene bis-quaternary ammonium salts. Nature 161, 718–719 (1948)
Barlow, R.B., Vane, J.R.: The ganglion-blocking properties of hexamethylene bisdialkylsul- phonium salts. Br. J. Pharmacol. 11, 198–201 (1956)
Barlow, R.B., Zoller, A.: Some effects of long chain polymethylene bis-onium salts on junctional transmission in the peripheral nervous system. Br. J. Pharmacol. 23, 131–150 (1964)
Bein, H.J., Meier, R.: Zur Pharmakologie des N,N,N′,N′-3-Pentamethyl-N,N′,-diäthyl-3-azapentan-1,5-diammonium-dibromid (Ciba 9295), einer ganglionar hemmenden Substanz (Kurze Mitteilung). Experientia 6, 351–353 (1950)
Bickerton, R.K., Jacquart, M.L., Kinnard, W.J., Bianculli, J.A., Buckley, J.T.: Tetrahydroiso-quinoline and tetrahydroquinoline derivatives. J. Am. Pharm. Assoc. 49, 183–186 (1960)
Brown, D.M., Turner, B.H.: The ganglionic blocking activity of a series of tertiary sulphonium quaternary ammonium salts. J. Pharm. Pharmacol. 11, suppl. 95, 95–102 T (1959)
Buckley, J.P., Jacquart, M.L., Bickerton, R.K., Hudak, W.J., Schalit, F.M, Defeo, J.J, Bianculli, J.A.: An evaluation of certain hypotensive agents IV. Diquaternarized piperidine derivatives. J. Am. Pharm. Assoc. 49, 586–589 (1960)
Cavallini, G., Mantegazza, P., Massarani, E, Tommasini, R.: Sull’attivita ganglioplegica di alcuni derivati alchilaminici dello stilbene e del difenily. Farmaco [Sci.] 8, 2–16 (1953)
Cavallito, C.J, Gray, A.P.: Chemical nature and pharmacological actions of quaternaryammonium salts. In: Fortschritte der Arzneimittelforschung. Jucker, E. (ed.), Vol. II, 135–226 Basel, Stuttgart: Birkhäuser 1960
Cavallito, C.J, Gray, A.P, O’Dell, T.B.: Sites of action of some unsymmetric bis-quaternary hypotensive agents. Arch. Int. Pharmacodyn. Ther 101, 38–48 (1955)
Chou, T.C., de Elio, F.J.: The antieurare activity of eserine on the superior cervical ganglion of the cat. Br. J. Pharmacol. 3, 113–115 (1948)
Cook, D.L, Hambourger, W.E, Blanchi, R.G.: Pharmacology of a new autonomic ganglion blocking agent, 2,6-dimethyl-1,1-diethyl piperidinium bromide (SC-1950). J. Pharmacol. Exp. Ther. 99, 435–443 (1950)
Cusic, J.W, Robinson, R.A.: Autonomic blocking agents. II. Alkamine esters and their quaternaries. J. Org. Chem. 16, 1921–1930 (1951)
O’Dell, T.B, Napoli, M.D.: Pharmacology of some unsymmetrical bisquaternary hypotensive agents — substituted pyridine and piperidine derivatives. J. Pharmacol. Exp. Ther. 120, 438–446 (1957)
O’Dell, T.B, Luna, C., Napoli, M.D.: Pharmacology of some new unsymmetrical bisquaternary hypotensive agents — carboline derivatives. J. Pharmacol. Exp. Ther. 114, 306–316 (1965a)
O’Dell, T.B, Luna, C., Napoli, M.D.: Pharmacology of some new unsymmetrical bisquaternary hypotensive agents — isoquinoline derivatives. J. Pharmacol. Exp. Ther. 114, 317–325 (1955b)
Delia Bella, D.: Ober ein ganglionlähmendes Sulphoniumderivat: das Hexamethylen-1,6-bis- Dimethylsulphonium. Arch. Exp. Pathol. Pharmakol. 226, 335–339 (1955)
Fakstorp, J.T., Pedersen, J.G.A.: Ganglionic blocking activity of homologues and analogues of bis-choline ether salts. Acta Pharmacol. Toxicol. (Kbh) 13, 359–367 (1957)
Fakstorp, J.T., Pedersen, J.G.A.: Ganglion-blocking action of some substituted choline phenyl ethers. Acta Pharmacol. Toxicol. (Kbh) 14, 148–152 (1958)
Fakstorp, J.T, Pedersen, J.G.A, Poulsen, E, Schilling, M.: Ganglionic blocking activity of bis-trialkylammoniumethyl ether salts and their branched homologues. Acta Pharmacol. Toxicol. (Kbh) 13, 52–58 (1957)
Ginzel, R.H, Klupp, H, Kraupp, O., Werner, G.: Ganglionärblockierende Wirkungen von Polymethylen-bis-Phosphonium-Verbindungen. Arch. Exp. Pathol. Pharmakol. 221, 336–349 (1954)
Di Gregorio, G.J, Dipalma, J.R.: Some pharmacological actions of 2-phenylquinoline methiodide. Br. J. Pharmacol. 30, 531–540 (1967)
Gyermek, L, Nádor, K.: Studies on cholinergic blocking substances. II. Correlations between structure and effect in antimuscarine, ganglion blocking and curare-like actions of mono- and bis-quaternary ammonium compounds. Acta Physiol. Hung. 3, 183–193 (1952)
Gyermek, L, Nádor, K.: Studies on cholinergic blocking substances V. The pharmacology of monoquaternary tropeines acting on vegetative ganglia. Acta Physiol. Hung. 4, 341–354 (1953)
Gyermek, L, Nádor, K.: The pharmacology of propane compounds in relation to their steric structure. J. Pharm. Pharmacol. 9, 209–229 (1957)
Ing, H.R.: Structure-action relationships of hypotensive drugs. In: Hypotensive drugs. Harington, M. (ed.) 7–22, London, New York: Pergamon Press 1957
Jannasch, R.: Ganglienblocker. Pharm. Praxis. Beilage Nr. 7 zur Pharmazie 22, 198–204 (1967)
Kharkevich, D.A.: Ganglionic agents. Moskva: Medgiz 1962
Lape, H.E., Hoppe, J.O.: The use of serial carotid occlusion, nictitating membrane, and cross-circulation technics in the investigation of the central hypotensive activity of ganglionic blocking agents. J. Pharmacol. Exp. Ther. 116, 453–461 (1956)
Lape, H.E., Fort, D.J., Hoppe, J.O.: Observations on the ganglionic blocking properties of a series of biquaternary propane derivatives. J. Pharmacol. Exp. Ther. 116, 462–468 (1956)
Mason, D.F.J., Wien, R.: The actions of heterocyclic bis-quaternary compounds especially of a pyrrolidinium series. Br. J. Pharmacol. 10, 124–132 (1955)
Moe, G.K., Freyburger, W.A.: Ganglionic blocking agents. Pharmacol. Rev. 2, 61–95 (1950)
Nádor, K.: Ganglionblocker. In: Fortschritte der Arzneimittelforschung. Jucker, E. (ed.), Vol. II, 297–416. Basel, Stuttgart: Birkhäuser 1960
Pallazo, G., Virno, M.: Farmaco [Sci.] 9, 3 (1959); Le. Nádor, K.: Ganglionblocker. In: Fortschritte der Arzneimittelforschung. Jucker, E. (ed.), Vol. II, 297–416. Basel, Stuttgart: Birkhäuser 1960
Paton, W.D.M.: The uses of the methonium compounds. J. R. Inst. Publ. Health Hyg. — February, 1953, pp. 1–20
Paton, W.D.M., Zaimis, E.J.: Curare-like action of polymethylene bis-quaternary ammonium salts. Nature 161, 718–719 (1948)
Paton, W.D.M., Zaimis, E.J.: The pharmacological actions of polymethylene bistrimethyl- ammonium salts. Br. J. Pharmacol. 4, 381–400 (1949)
Paton, W.D.M., Zaimis, E.J.: Paralysis of autonomic ganglia by methonium salts. Br. J. Pharmacol. 6, 155–168 (1951)
Paton, W.D.M., Zaimis, F.J.: The methonium compounds. Pharmacol. Rev. 4, 219–253 (1952)
Plummer, A.J., Trapold, J.H., Schneider, J.A., Maxwell, R.A., Earl, A.E.: Ganglionic blockade by a new bisquaternary series including chlorisondamine dimethochloride. J. Pharmacol. Exp.Ther. 115, 172–184 (1955)
Protiva, M., Jílek, J.O., Exner, O.: Látky blokující sympatická ganglia I. Sulfoniovä analoga nižších methoniumjodidů. Chem. Listy 47, 580–583 (1953)
Robinson, R.A.: Autonomic blocking agents. I. Branched aliphatic quaternary ammonium and analogous cyclic ammonium salts. J. Org. Chem. 16, 1911–1920 (1951)
Van Rossum, J. M.: Classification and molecular pharmacology of ganglionic blocking agents. Part II. Mode of action of competitive and non-competitive ganglionic blocking agents. Int. J. Neuropharmacol. 1, 403–421 (1962)
Sharapov, I.M.: On the pharmacology of dioquine. Farmakol. Toksikol. 20, no. 6, pp. 9–15 (1957)
Sharapov, I.M.: On the pharmacology of dicoline. Farmakol. Toksikol. 21, No. 1, 19–24 (1958)
Standaert, F.G., Friess, S.L., Doty, R.O.: Comparative ganglion-blocking potencies of the geometric isomers of two cyclic 1,2-amino alcohols. J. Med. Pharm. Chem. 1, 459–466 (1959)
Tommasini, R., Passerini, N.: Attivita ganglioplegica di une série di derivati mono-e bis-quaternari del 3-azabiciclo-(3.3.1)-nonano. Nota I. Farmaco [Sci.] 14, 544–553 (1959)
Trčka, V., Lorencová, L.: Látky blokující sympatická ganglia V. Farmakologie novych derivátů několika typů. Čs. Farmacie 6, 194–197 (1957)
Trčka, V., Vaněček, M.: Nekteré nové typy ganglioplegik. Čs. Farmacie 8, 316–325 (1959)
Trendelenburg, U.: Pharmacology of autonomic ganglia. Ann. Rev. Pharmacol. Toxicol. 1, 219–238 (1961)
Triggle, D.J.: Cholinergic mechanisms: Blockade at ganglionic synapses. Chemical aspects of the autonomic nervous system. London, New York: Academic Press 1965
Triggle, D.J.: Analogs and antagonists of acetylcholine and norephinephrine: The relationships between chemical structure and biological activity. Neurotransmitter — receptor interactions. London, New York: Academic Press 1971
Vejdělek, Z.J.: Neue Typen synthetischer Verbindungen mit ganglienblockierender Wirkung. Arzneim. Forsch. 10, 808–811 (1960)
Wien, R.: Relation of chemical structure of compounds to their action on autonomic ganglia. Arch. Int. Pharmacodyn. Ther. 97, 395–406 (1954)
Wien, R., Mason, D.F.J.: The pharmacological actions of a series of phenyl alcane p-ω-bis(trialkylammonium) compounds. Br. J. Pharmacol. 8, 306–314 (1953)
Wien, R., Mason, D.F.J., Edge, N.D., Langston, G.T.: The ganglion blocking properties of homologous compounds in the methonium series. Br. J. Pharmacol. 7, 534–541 (1952)
Winbury, M.M.: Autonomic blocking compounds. I. Ganglion blocking action of some aliphatic quaternary ammonium salts, related alkyl piperidinium salts and 1,2,3,4-tetrahydroiso-quinolinium salts. J. Pharmacol. Exp. Ther. 105, 327–336 (1952)
Winbury, M.M., Cook, D.L., Hambourger, W.E.: Autonomic blocking compounds II. Influence of secondary alkyl groups on ganglion blocking activity of various quaternary ammonium derivatives. Arch. Int. Pharmacodyn. Ther. 97, 125–140 (1954)
Zaimis, E.J.: The interruption of ganglionic transmission and some of its problems. J. Pharm. Pharmacol. 7, 497–511(1955)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Trčka, V. (1980). Relationship Between Chemical Structure and Ganglion-Blocking Activity. In: Kharkevich, D.A. (eds) Pharmacology of Ganglionic Transmission. Handbook of Experimental Pharmacology, vol 53. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67397-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-67397-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67399-3
Online ISBN: 978-3-642-67397-9
eBook Packages: Springer Book Archive